ganymed press london limited
ganymed press london limited Company Information
Company Number
00438725
Next Accounts
Dec 2024
Industry
Other publishing activities
Shareholders
medici society ltd
Group Structure
View All
Contact
Registered Address
19-23 white lion street, islington, london, N1 9PD
ganymed press london limited Estimated Valuation
Pomanda estimates the enterprise value of GANYMED PRESS LONDON LIMITED at £72.9k based on a Turnover of £151.6k and 0.48x industry multiple (adjusted for size and gross margin).
ganymed press london limited Estimated Valuation
Pomanda estimates the enterprise value of GANYMED PRESS LONDON LIMITED at £0 based on an EBITDA of £0 and a 2.71x industry multiple (adjusted for size and gross margin).
ganymed press london limited Estimated Valuation
Pomanda estimates the enterprise value of GANYMED PRESS LONDON LIMITED at £65.8k based on Net Assets of £34.3k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ganymed Press London Limited Overview
Ganymed Press London Limited is a live company located in london, N1 9PD with a Companies House number of 00438725. It operates in the other publishing activities sector, SIC Code 58190. Founded in July 1947, it's largest shareholder is medici society ltd with a 100% stake. Ganymed Press London Limited is a mature, micro sized company, Pomanda has estimated its turnover at £151.6k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ganymed Press London Limited Health Check
Pomanda's financial health check has awarded Ganymed Press London Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
4 Weak
Size
annual sales of £151.6k, make it smaller than the average company (£985.4k)
- Ganymed Press London Limited
£985.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a similar rate (3.5%)
- Ganymed Press London Limited
3.5% - Industry AVG
Production
with a gross margin of 33.2%, this company has a higher cost of product (57.5%)
- Ganymed Press London Limited
57.5% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Ganymed Press London Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (21)
- Ganymed Press London Limited
21 - Industry AVG
Pay Structure
on an average salary of £50.7k, the company has an equivalent pay structure (£50.7k)
- Ganymed Press London Limited
£50.7k - Industry AVG
Efficiency
resulting in sales per employee of £151.6k, this is more efficient (£111.5k)
- Ganymed Press London Limited
£111.5k - Industry AVG
Debtor Days
it gets paid by customers after 82 days, this is later than average (46 days)
- Ganymed Press London Limited
46 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Ganymed Press London Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ganymed Press London Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ganymed Press London Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Ganymed Press London Limited
- - Industry AVG
GANYMED PRESS LONDON LIMITED financials
Ganymed Press London Limited's latest turnover from March 2023 is estimated at £151.6 thousand and the company has net assets of £34.3 thousand. According to their latest financial statements, we estimate that Ganymed Press London Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | ||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 34,311 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ganymed press london limited Credit Report and Business Information
Ganymed Press London Limited Competitor Analysis
Perform a competitor analysis for ganymed press london limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other micro companies, companies in N 1 area or any other competitors across 12 key performance metrics.
ganymed press london limited Ownership
GANYMED PRESS LONDON LIMITED group structure
Ganymed Press London Limited has no subsidiary companies.
Ultimate parent company
1 parent
GANYMED PRESS LONDON LIMITED
00438725
ganymed press london limited directors
Ganymed Press London Limited currently has 2 directors. The longest serving directors include Mrs Priscilla Meath Baker (Jul 1991) and Mr Benjamin Bristol (Jul 2002).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Priscilla Meath Baker | United Kingdom | 87 years | Jul 1991 | - | Director |
| Mr Benjamin Bristol | 52 years | Jul 2002 | - | Director |
P&L
March 2023turnover
151.6k
+5%
operating profit
0
0%
gross margin
33.2%
-14.67%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
34.3k
0%
total assets
34.3k
0%
cash
0
0%
net assets
Total assets minus all liabilities
ganymed press london limited company details
company number
00438725
Type
Private limited with Share Capital
industry
58190 - Other publishing activities
incorporation date
July 1947
age
77
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
19-23 white lion street, islington, london, N1 9PD
Bank
BARCLAYS BANK PLC
Legal Advisor
-
ganymed press london limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ganymed press london limited.
ganymed press london limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GANYMED PRESS LONDON LIMITED. This can take several minutes, an email will notify you when this has completed.
ganymed press london limited Companies House Filings - See Documents
| date | description | view/download |
|---|
